• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Amgen Kyprolis Marketing Team

anonymous

Guest
Between Brian Health, Laura Brand, the new Promo director who was an Enbrel DM....why does no one here understand oncology?

No wonder even with new data from clinical trial readouts, this team is still struggling to get out of the $130-$140M US sales a quarter for the last 2 years.

Some one buy Amgen and put a real marketing team in there.
 

<



No one here at Amgen is a true marketer. It is nothing but a rotational role..check the box to promotion.it is always the sales that gets stuck with ridiculous quota and no excuses.
Between Brian Health, Laura Brand, the new Promo director who was an Enbrel DM....why does no one here understand oncology?

No wonder even with new data from clinical trial readouts, this team is still struggling to get out of the $130-$140M US sales a quarter for the last 2 years.

Some one buy Amgen and put a real marketing team in there.
 




Between Brian Health, Laura Brand, the new Promo director who was an Enbrel DM....why does no one here understand oncology?

No wonder even with new data from clinical trial readouts, this team is still struggling to get out of the $130-$140M US sales a quarter for the last 2 years.

Some one buy Amgen and put a real marketing team in there.


And their collective hem/onc experience is what? Sorry but supportive care does not count. So a few months being a rotational DM with Vectibix is not real oncology experience. BH then went on to ruin Blin and create a mass exodus. Why would anyone think that Kyprolis will be successful under the watch of inexperienced sales and marketing people?
 




And their collective hem/onc experience is what? Sorry but supportive care does not count. So a few months being a rotational DM with Vectibix is not real oncology experience. BH then went on to ruin Blin and create a mass exodus. Why would anyone think that Kyprolis will be successful under the watch of inexperienced sales and marketing people?


All those that left Blin were Onyx Pharmaceutical hold overs and losers.

Brian Health went to Harvard Business School. No experience needed when you are a HBS alumni like Bob Bradway.
 








All those that left Blin were Onyx Pharmaceutical hold overs and losers.

Brian Health went to Harvard Business School. No experience needed when you are a HBS alumni like Bob Bradway.

The best oncology reps amgen had were from Old school onyx and amgen managed to scare them all away. Goes to show you how insane this company is. BH is worthless as is all amgen oncology leaders.